Role of genomic imprinting in Wilms' tumour and overgrowth disorders

Medical and Pediatric Oncology

Volumn 27, Issue 5, 1996, Pages 470-475

  Reeve, Anthony E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

H19 IGF2; imprinted domain; Wilms' tumour

Indexed keywords

SOMATOMEDIN B;

ANIMAL MODEL; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BODY GROWTH; CANCER SUSCEPTIBILITY; CHROMOSOME 11P; CHROMOSOME TRANSLOCATION; GENOME IMPRINTING; GIGANTISM; GROWTH DISORDER; HUMAN; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BECKWITH-WIEDEMANN SYNDROME; CHROMOSOMES, HUMAN, PAIR 11; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; GIGANTISM; GROWTH; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MICE; MUSCLE PROTEINS; RNA, UNTRANSLATED; TRANSLOCATION, GENETIC; WILMS TUMOR;

EID: 0029793545     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199611)27:5<470::AID-MPO14>3.0.CO;2-E     Document Type: Article

References (50)

1. Miller RW, Fraumeni JF, Manning MD: Association of Wilms' tumour with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922-927, 1964.
2. Knudson AG, Strong LC: Mutation and cancer: A model for Wilms' tumour of the kidney. J Nat Cancer Institute 48:313-324, 1972.
3. Francke U, Holmes LB, Atkins L, Riccardi VM: Aniridia-Wilms' tumor association: Evidence for specific deletion of 11p13. Cytogenet Cell Genet 24;185-192, 1979.
4. Koufos A, Hansen MF, Lampkin BC, Workman ML, NG, Jenkins NA, Cavenee WK: Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature 309:170-174, 1984.
5. Orkin ST, Goldman DS, Sallan SE. Development of homozygosity of chromosome 11p markers in Wilms' tumor. Nature 309:172-174, 1984.
6. Fearon ER, Vogelstein B, Feinberg AP: Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 309:176-178, 1984.
7. Reeve AE, Housiaux PJ, Gardner RJM, Chewings WE, Grindley RM, Millow LJ: Loss of a Harvey ras allele in sporadic Wilms' tumour. Nature 309:174-176, 1984.
8. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983.
9. Call KM, Ito CY, Buckler AJ, Pelletier J, Haber DA, Glaser T, Rose EA, Jones C, Housman D: Isolation of a cDNA in the WAGR region: A candidate gene for Wilms' tumour. Am J Hum Genet 45:A179, 1989.
10. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990.
11. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL: Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41-48, 1988.
12. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK: Preferential loss of maternal alleles in sporadic Wilms' rumour. Oncogene 5:1665-1668, 1990.
13. Reeve AE, Sih SA, Raizis AM, Feinberg AP: Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumour cells. Mol Cell Biol 9:1799-1803, 1989.
14. Schroeder WT, Chao L-Y, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF: Nonrandom loss of maternal chromosome 11 alleles in Wilms' tumours. Am J Hum Genet 40:413-420, 1987.
15. Wilkins RJ: Genomic imprinting and carcinogenesis. Lancet i:329-331, 1988.
16. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, Sapienza C: A model for embryonal rhabdomyosarcoma tumorigenesis that involves genomic imprinting. Proc Natl Acad Sci USA 86:7480-7484, 1989.
17. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK: Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 336:374-376, 1988.
18. Huff V, Compton DA, Chao L-Y, Strong LC, Geiser CF, Saunders GF: Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 336:377-378, 1988.
19. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ: Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317:258-260, 1985.
20. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ: Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 317:261-262, 1985.
21. Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, Ullrich A, Brechot C: Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumours, and liver cirrhosis. Cancer Res 48:6844-6849, 1988.
22. Gloudemans T, Prinsen I, Van Unnik MAM, Lips CJM, Den Otter W, Sussenbach JS: Insulin-like growth factor gene expression in human smooth muscle tumors. Cancer Res 50:6689-6695, 1990.
23. Haselbacher GK, Irminger J-C, Zapf J, Ziegler WH, Humbel RE: Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms' tumours: Expression at the mRNA and protein level. Proc Natl Acad Sci USA 84:1104-1106, 1987.
24. Hoppener JWM, Mosselman S, Roholl PJM, Lambrechts C, Slebos RJC, de Pagter-Holthuizen P, Lips CJM, Jansz HS, Sussenbach JS: Expression of insulin-like growth factor I and II genes in human smooth muscle tumours. EMBO J 7:1379-1385, 1988.
25. Su T, Liu W-Y, Han S-H, Jansen M, Yang-Fen TL, P'eng F-K, Chou C-K: Transcripts of the insulin-like growth factors 1 and 11 in human hepatoma. Cancer Res 49:1773-1777, 1989.
26. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691-6696, 1988.
27. DeChiara M, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859, 1991.
28. Little M, van Heyningen V, Hastie N: Dads and disomy and disease. Nature 351:609-610, 1991.
29. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992.
30. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP: Relaxation of imprinted genes in human cancer. Nature 362:747-749, 1993.
31. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE: Relaxation of insulin-like growth factor gene imprinting implicated in Wilms' tumour. Nature 362:749-751, 1993.
32. Yun K, Molenaar AJ, Fidler AM, Mark AJ, Eccles MR, Becroft DMO, Reeve AE: Insulin-like growth factor II messenger ribonucleic acid expression in Wilms' tumor, nephrogenic rest, and kidney. Lab Invest 69:603-615, 1993.
33. Bennington JL, Beckwith JB: Tumors of the kidney, renal peivis and ureter. Washington DC: Armed Forces of Pathology. Atlas of Tumor Pathology. Second Series, Fascicle 12, 1974.
34. Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith AC, Barton SC, Reik W, Surani MA: Parental imprinting: Potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev 6:1843-1856, 1992.
35. Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber D: Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet 5:363-367, 1993.
36. Little MH, Ablett G, Smith PJ: Enhanced expression of insulin-like growth factor II is not a necessary event in Wilms' tumour progression. Carcinogenesis 8:865-868, 1987.
37. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B: Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet 7:440-447, 1994.
38. Yun K, Fidler AE, Eccles MR, Reeve AE: Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumour. Cancer Res 53:5166-5171, 1993.
39. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet 7:433-439, 1994.
40. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE: Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms' tumour. Proc Natl Acad Sci USA 92:2159-2163, 1995.
41. Junien C, Henry I: Genetics of Wilms' tumor: A blend of aberrant development and genomic imprinting. Kidney Internat 46:1264-1279, 1994.
42. Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C: Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667, 1991.
43. Grundy P, Telzerow P, Paterson MC, Haber D, Berman B, Li F, Garber J: Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms. The Lancet 338:1079-1080, 1991.
44. Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, Niikawa N, Tonoki H, Nakamura Y, de Boer EG, Slater RM, John R, Cowell JK, Junien C, Henry I, Tommerup N, Weksberg R, Pueschel SM, Leschot NJ, Westerveld A: Parental imprinting of human chromosome region 11p 15.3-pter involved in the Beckwith-Wiedernann Syndrome and various human neoplasia. Eur J Hum Genet 2:3-23, 1994.
45. Pueschel SM, Padre-Mendoza T: Chromosome 11 and Beckwith-Wiedemann syndrome. J Pediatrics 104:484-485, 1984.
46. Norman AM, Read AP, Clayton-Smith J, Andrews T, Donnai D: Recurrent Wiedemann-Beckwith syndrome with inversion of chromosome (11) (p11.2p15.5) Am J Med Genet 42:638-641, 1992.
47. Tartof K, Henikoff S: Trans-sensing effects from Drosophila to humans. Cell 65:201-203, 1991.
48. Weksberg R, Shen DR, Song QL, Squire J: Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet 5:143-149, 1993.
49. Ogawa O, Becroft DM, Morison IM, Eccles MR, Sheen JE, Mauger DC, Reeve AE: Constitutional relaxation of insulin-like growth factor 2 gene imprinting associated with Wilms tumour and gigantism. Nature Genet 5:408-412, 1993.
50. Leighton PA, Ingram RS, Eggenscwiler J, Efstradiadis A, Tilghman SM: Disruption of imprinting caused by deletion of the H19 region in mice. Nature 375:34-39, 1995.